Novabay pharmaceuticals, inc. (NBY)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Sep'10Jun'10
Sales:
Total sales, net

1,892

1,704

1,615

1,789

1,491

3,625

3,142

2,794

2,947

6,316

4,091

4,122

3,701

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Product cost of goods sold

581

593

401

403

341

441

332

479

251

977

521

698

588

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Product revenue, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,262

2,654

1,655

1,587

1,136

931

492

-

90

21

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

License, collaboration and distribution revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

38

-

1,035

790

914

1,067

3,617

856

1,315

-

2,762

4,527

-

-

-

License and collaboration revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,490

2,086

2,548

Other revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

176

9

64

48

64

77

46

144

62

102

62

3,105

65

41

43

33

25

15

5

-

10

-

-

-

-

Total sales, net

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,438

2,663

1,719

1,635

1,200

1,008

538

-

152

123

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Product revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

188

-

-1

17

63

-

-

-

-

-

-

-

-

-

-

Product cost of goods sold

-

-

-

-

-

-

-

-

-

-

-

-

-

-

566

479

611

591

269

253

148

296

42

18

130

81

43

16

22

-

-

-

-

-

-

-

-

-

-

Gross profit

1,311

1,111

1,214

1,386

1,150

3,184

2,810

2,315

2,696

5,339

3,570

3,424

3,113

3,269

2,872

2,184

1,108

1,044

931

755

390

295

110

105

58

3,317

-44

1

41

-

-

-

-

-

-

-

-

-

-

Total other revenue

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

100

-

1,100

831

957

1,100

3,642

871

1,320

1,230

2,772

4,527

2,490

2,086

2,548

Operating expenses:
Research and development

9

18

49

32

85

107

45

61

46

146

132

70

62

156

4

278

933

1,225

1,563

1,357

1,583

2,385

2,312

2,238

2,548

4,086

2,513

2,937

2,925

2,119

2,514

2,378

2,264

2,199

2,023

2,769

2,920

2,245

2,129

Sales and marketing

1,560

2,157

1,544

1,535

3,531

3,186

3,230

2,977

3,396

3,299

3,296

3,376

3,740

3,149

2,663

2,853

3,144

3,263

3,035

2,311

1,914

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

General and administrative

1,277

1,174

1,333

1,198

1,605

1,502

1,344

1,360

1,622

1,502

2,311

1,735

3,088

1,994

2,266

1,293

1,682

2,825

1,681

1,946

1,554

-

-

-

-

-

-

2,045

1,560

-

1,234

1,368

1,541

1,499

1,097

1,318

1,515

1,487

1,611

Sales, general and administrative

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,911

1,653

1,708

-

1,525

-

-

-

-

-

-

-

-

-

-

-

-

Total operating expenses

2,846

3,349

2,926

2,765

5,221

4,795

4,619

4,398

5,064

4,947

5,739

5,181

6,890

5,299

4,933

4,424

5,759

7,313

6,279

5,614

5,051

5,122

4,223

3,891

4,236

5,296

4,038

4,982

4,485

3,949

3,748

3,746

3,805

3,698

3,120

4,087

4,435

3,732

3,740

Operating loss

-1,535

-2,238

-1,712

-1,379

-4,071

-1,611

-1,809

-2,083

-2,368

392

-2,169

-1,757

-3,777

-2,030

-2,061

-2,240

-4,651

-6,269

-5,348

-4,859

-4,661

-4,927

-4,113

-3,786

-4,078

-4,867

-2,982

-4,150

-3,487

-2,843

-106

-2,875

-2,485

-2,468

-348

440

-1,945

-1,646

-1,192

Non-cash gain (loss) on changes in fair value of warrant liability

-137

187

-1,480

487

57

-340

-267

-490

-214

-400

281

-15

235

-

1,671

424

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash gain on changes in fair value of embedded derivative liability

2

-

669

-246

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non cash loss on changes in fair value of warrant liability

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-385

-

139

0

34

451

-104

797

520

727

-866

104

-520

637

209

628

-35

-

453

-

-

-

-

Other expense, net

-186

-259

-719

-387

-60

6

4

5

4

3

3

4

2

1

-4

-24

-41

81

-31

-22

-11

0

-2

57

-7

-

3

5

-

-160

-17

27

-5

6

6

-11

-31

4

-6

Loss before provision for income taxes

-1,582

-2,683

-282

-2,499

-4,188

-1,265

-1,538

-1,588

-2,150

795

-2,447

-1,738

-4,010

-

-3,736

-2,688

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Loss before provision for income taxes

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-5,077

-

-5,240

-4,881

-4,638

-4,476

-4,219

-2,932

-3,565

-4,147

-3,845

-4,041

-4,007

-2,366

86

-2,220

-2,525

-3,647

111

429

-1,976

-1,642

-1,198

Provision for income taxes

-

3

0

2

1

-

-

1

-

2

0

0

1

0

0

2

0

-8

2

6

2

-

0

10

-

-10

3

7

2

-16

6

6

6

-19

5

4

12

-

-

Net loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-4,468

-4,219

-2,942

-3,565

-4,137

-3,848

-4,048

-4,009

-2,350

80

-2,226

-2,531

-3,628

106

425

-1,988

-1,642

-1,198

Change in Unrealized gains on available for sale securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10

3

0

2

-2

6

-8

2

16

33

-20

2

-

-

-

-

-

-

Comprehensive loss

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-4,458

-4,216

-2,942

-3,563

-4,139

-3,842

-4,056

-4,007

-2,334

113

-2,246

-2,529

-

-

-

-

-

-

Net loss and comprehensive loss

-1,582

-2,686

-282

-2,501

-4,189

-1,268

-1,538

-1,589

-2,150

793

-2,447

-1,738

-4,011

-1,648

-3,736

-2,690

-5,077

-4,204

-5,242

-4,887

-4,640

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net loss per share attributable to common stockholders (basic and diluted) (in dollars per share)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-0.34

-0.36

-1.24

-1.08

-1.77

-1.84

-2.13

-7.43

-0.08

-0.06

-0.08

-10.19

-0.10

-0.11

-0.11

-

-

-0.08

-0.09

-

-

0.02

-0.08

-0.07

-0.05

Change in unrealized gains (losses) on available-for-sale securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-5

4

14

-

-

Total comprehensive income (loss)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

101

429

-1,974

-

-

Net loss per share attributable to common stockholders (basic and diluted) (in dollars per share)

-0.06

-0.08

-0.01

-0.14

-0.25

-0.08

-0.09

-0.09

-0.13

0.05

-0.16

-0.11

-0.26

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.00

-

-

-

0.00

-

-

-

-

Net loss per share attributable to common stockholders (diluted) (in dollars per share)

-

-

-0.02

-0.14

-

-0.09

-0.11

-0.12

-0.14

0.05

-0.16

-0.11

-0.26

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0.00

-

-

-

0.00

-

-

-

-

Weighted-average shares of common stock outstanding used in computing net loss per share of common stock (in shares)

-

-

-

-

-

-

-

-

-

-

-

-

-

-

10,913

7,407

4,086

5,523

2,957

2,653

2

-138,986

50,821

50,767

45,338

-105,381

37,467

37,266

36,756

-

-

-

-

-

-

-

-

-

-

Weighted-average shares of common stock used in computing net loss per share attributable to common stockholders (basic and diluted) (in shares)

27,978

27,762

23,096

18,613

17,093

17,100

17,089

17,089

16,406

15,380

15,324

15,308

15,284

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

28,861

-

-

-

27,902

-

-

-

-

Weighted-average shares of common stock outstanding used in computing net loss per share of common stock (diluted) (in shares)

-

-

23,213

18,613

-

17,122

17,148

17,292

16,670

15,380

15,324

15,308

15,284

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

29,284

28,671

28,572

28,282

27,902

23,480

23,428

23,335

23,315

Product [Member]
Total sales, net

1,892

1,702

1,615

1,789

1,450

3,604

3,142

2,794

2,934

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Product and Service, Other [Member]
Total sales, net

-

2

0

0

41

21

0

0

13

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-